Jacobson Pharma Corporation Limited
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Jacobson Pharma Corporation Limited
Cold chain distribution requirements are a major downside for mRNA-based vaccines, but Moderna may have the edge over Pfizer/BioNTech's candidate.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2017.
- Generic Drugs
- Other Names / Subsidiaries
- Jacobson Group